Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00590187
Show Display Options
Rank Status Study
1 Unknown  Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Condition: Acute Myeloid Leukemia
Interventions: Drug: sapacitabine;   Drug: Sapacitabine

Indicates status has not been verified in more than two years